Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
US Department of Justice
Federal Trade Commission
Teva
Deloitte
Chubb
Harvard Business School
AstraZeneca
Accenture

Generated: June 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 202595

« Back to Dashboard

NDA 202595 describes OSELTAMIVIR PHOSPHATE, which is a drug marketed by Amneal Pharms, Hetero Labs Ltd Iii, Lupin Atlantis, Macleods Pharms Ltd, Natco Pharma Ltd, Nesher Pharms, Strides Pharma, and Alvogen Pine Brook, and is included in ten NDAs. It is available from fifteen suppliers. Additional details are available on the OSELTAMIVIR PHOSPHATE profile page.

The generic ingredient in OSELTAMIVIR PHOSPHATE is oseltamivir phosphate. There are seven drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the oseltamivir phosphate profile page.
Summary for 202595
Tradename:OSELTAMIVIR PHOSPHATE
Applicant:Natco Pharma Ltd
Ingredient:oseltamivir phosphate
Patents:0
Therapeutic Class:Antivirals
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 202595
Suppliers and Packaging for NDA: 202595
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
OSELTAMIVIR PHOSPHATE oseltamivir phosphate CAPSULE;ORAL 202595 ANDA Alvogen Inc. 47781-468 N 47781-468-13
OSELTAMIVIR PHOSPHATE oseltamivir phosphate CAPSULE;ORAL 202595 ANDA Alvogen Inc. 47781-469 N 47781-469-13

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrengthEQ 30MG BASE
Approval Date:Aug 3, 2016TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrengthEQ 45MG BASE
Approval Date:Aug 3, 2016TE:ABRLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrengthEQ 75MG BASE
Approval Date:Aug 3, 2016TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Mallinckrodt
Accenture
Chinese Patent Office
Moodys
Colorcon
Healthtrust
Citi
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.